High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 890-897

  Moskowitz, Craig H ^a   Yahalom, Joachim ^a   Zelenetz, Andrew D ^a   Zhang, Zhigang ^a   Filippa, Daniel ^a   Teruya Feldstein, Julie ^a   Kewalramani, Tarun ^a   Moskowitz, Alison J ^a   Rice, Robert David ^a   Maragulia, Jocelyn ^a   Vanak, Jill ^a   Trippett, Tanya ^a   Hamlin, Paul ^a   Horowitz, Steven ^a   Noy, Ariela ^a   O'Connor, Owen A ^a   Portlock, Carol ^a   Straus, David ^a   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

High dose chemoradiotherapy; Hodgkin Lymphoma; HSCT

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; EVENT FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEPTIC SHOCK; TREATMENT OUTCOME; TREATMENT RESPONSE; ADJUVANT THERAPY; CANCER STAGING; CLINICAL TRIAL; EPIDEMIOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; EPIDEMIOLOGIC METHODS; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECURRENCE; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649207012     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08037.x     Document Type: Article

References (36)

1. Alegre, A., Diaz-Mediavilla, J., San-Miguel, J., Martinez, R., Garcia Larana, J., Sureda, A., Lahuerta, J.J., Morales, D., Blade, J., Caballero, D., De la Rubia, J., Escudero, A., Diez-Martin, J.L., Hernandez-Navarro, F., Rifon, J., Odriozola, J., Brunet, S., De la Serna, J., Besalduch, J., Vidal, M.J., Solano, C., Leon, A., Sanchez, J.J., Martinez-Chamorro, C. Fernandez-Ranada, J.M. (1998) Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Espanol de Trasplante Hematopoyetico-GETH) and PETHEMA. Bone Marrow Transplantation, 21, 133 140.
2. Anderlini, P. Champlin, R.E. (2006) Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand? Biology of Blood and Marrow Transplantation, 12, 599 602.
3. Ansell, S.M., Horwitz, S.M., Engert, A., Khan, K.D., Lin, T., Strair, R., Keler, T., Graziano, R., Blanset, D., Yellin, M., Fischkoff, S., Assad, A. Borchmann, P. (2007) Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. Journal of Clinical Oncology, 25, 2764 2769.
4. Bartlett, N.L., Niedzwiecki, D., Johnson, J.L., Friedberg, J.W., Johnson, K.B., van Besien, K., Zelenetz, A.D., Cheson, B.D. Canellos, G.P. (2007) Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Annals of Oncology, 18, 1071 1079.
5. Bierman, P.J., Anderson, J.R., Freeman, M.B., Vose, J.M., Kessinger, A., Bishop, M.R. Armitage, J.O. (1996) High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Annals of Oncology, 7, 151 156.
6. Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M. Diehl, V. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579 586.
7. Colwill, R., Crump, M., Couture, F., Danish, R., Stewart, A.K., Sutton, D.M., Scott, J.G., Sutcliffe, S.B., Brandwein, J.M. Keating, A. (1995) Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. Journal of Clinical Oncology, 13, 396 402.
8. Czyz, J., Dziadziuszko, R., Knopinska-Posluszny, W., Hellmann, A., Kachel, L., Holowiecki, J., Czyz, A., Komarnicki, M., Osowiecki, M., Walewski, J., Jurczak, W. Skotnicki, A. (2007) Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure. Leukaemia & Lymphoma, 48, 535 541.
9. Diehl, L.F., Perry, D.J., Terebelo, H., Baldwin, P.E., Hurwitz, M., Kimball, D.B. Dorn, R.V. (1983) Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Cancer Treatment Reports, 67, 827 829.
10. Ferme, C., Mounier, N., Divine, M., Brice, P., Stamatoullas, A., Reman, O., Voillat, L., Jaubert, J., Lederlin, P., Colin, P., Berger, F. Salles, G. (2002) Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. Journal of Clinical Oncology, 20, 467 475.
11. Fung, H.C., Stiff, P., Schriber, J., Toor, A., Smith, E., Rodriguez, T., Krishnan, A., Molina, A., Smith, D., Ivers, B., Kogut, N., Popplewell, L., Rodriguez, R., Somlo, G., Forman, S.J. Nademanee, A. (2007) Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma. Biology of Blood and Marrow Transplantat, 13, 594 600.
12. Hagemeister, F.B., Purugganan, R., Podoloff, D.A., Hess, M., Rodriguez, M.A., McLaughlin, P., Swan, Jr., F., Romaguera, J.E. Cabanillas, F. (1994) The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy. Annals of Oncology, 5 (Suppl. 2 59 63.
13. Hoppe, R.T. (1998) Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease. Annals of Oncology, 9 (Suppl. 5 S87 S90.
14. Horning, S.J., Chao, N.J., Negrin, R.S., Hoppe, R.T., Long, G.D., Hu, W.W., Wong, R.M., Brown, B.W. Blume, K.G. (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Blood, 89, 801 813.
15. Jabbour, E., Hosing, C., Ayers, G., Nunez, R., Anderlini, P., Pro, B., Khouri, I., Younes, A., Hagemeister, F., Kwak, L. Fayad, L. (2007) Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer, 109, 2481 2489.
16. Josting, A., Franklin, J., May, M., Koch, P., Beykirch, M.K., Heinz, J., Rudolph, C., Diehl, V. Engert, A. (2002) New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. Journal of Clinical Oncology, 20, 221 230.
17. Juweid, M.E., Stroobants, S., Hoekstra, O.S., Mottaghy, F.M., Dietlein, M., Guermazi, A., Wiseman, G.A., Kostakoglu, L., Scheidhauer, K., Buck, A., Naumann, R., Spaepen, K., Hicks, R.J., Weber, W.A., Reske, S.N., Schwaiger, M., Schwartz, L.H., Zijlstra, J.M., Siegel, B.A. Cheson, B.D. (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. Journal of Clinical Oncology, 25, 571 578.
18. Kasamon, Y.L., Wahl, R.L. Swinnen, L.J. (2004) FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy. Current Opinion in Oncology, 16, 100 105.
19. Kaufman, J. Lonial, S. (2004) Multiple myeloma: the role of transplant and novel treatment strategies. Seminars in Oncology, 31, 99 105.
20. Kewalramani, T., Zelenetz, A.D., Nimer, S.D., Portlock, C., Straus, D., Noy, A., O'Connor, O., Filippa, D.A., Teruya-Feldstein, J., Gencarelli, A., Qin, J., Waxman, A., Yahalom, J. Moskowitz, C.H. (2004) Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood, 103, 3684 3688.
21. Leigh, B.R., Fox, K.A., Mack, C.F., Baier, M., Miller, T.P. Cassady, J.R. (1993) Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. International Journal of Radiation Oncology, Biology, Physics, 27, 855 862.
22. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051 1054.
23. Lister, T.A. Crowther, D. (1990) Staging for Hodgkin's disease. Seminars in Oncology, 17, 696 703.
24. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: cotswolds meeting. Journal of Clinical Oncology, 7, 1630 1636.
25. Moskowitz, C. (2004) An update on the management of relapsed and primary refractory Hodgkin's disease. Seminars in Oncology, 31, 54 59.
26. Moskowitz, C.H., Nimer, S.D., Zelenetz, A.D., Trippett, T., Hedrick, E.E., Filippa, D.A., Louie, D., Gonzales, M., Walits, J., Coady-Lyons, N., Qin, J., Frank, R., Bertino, J.R., Goy, A., Noy, A., O'Brien, J.P., Straus, D., Portlock, C.S. Yahalom, J. (2001) A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. Blood, 97, 616 623.
27. Peggs, K.S., Sureda, A., Qian, W., Caballero, D., Hunter, A., Urbano-Ispizua, A., Cavet, J., Ribera, J.M., Parker, A., Canales, M., Mahendra, P., Garcia-Conde, J., Milligan, D., Sanz, G., Thomson, K., Arranz, R., Goldstone, A.H., Alvarez, I., Linch, D.C., Sierra, J. Mackinnon, S. (2007) Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. British Journal of Haematology, 139, 70 80.
28. Proctor, S.J., Jackson, G.H., Lennard, A., Angus, B., Wood, K., Lucraft, H.L., White, J., Windebank, K. Taylor, P.R. (2003) Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK). Annals of Oncology, 14 (Suppl. 1 i47 i50.
29. Reece, D.E., Connors, J.M., Spinelli, J.J., Barnett, M.J., Fairey, R.N., Klingemann, H.G., Nantel, S.H., O'Reilly, S., Shepherd, J.D. Sutherland, H.J. (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83, 1193 1199.
30. Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., Boissevain, F., Zschaber, R., Muller, P., Kirchner, H., Lohri, A., Decker, S., Koch, B., Hasenclever, D., Goldstone, A.H. Diehl, V. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet, 359, 2065 2071.
31. Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Thomas, J., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L. Verhoef, G. (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood, 102, 53 59.
32. Svoboda, J., Andreadis, C., Elstrom, R., Chong, E.A., Downs, L.H., Berkowitz, A., Luger, S.M., Porter, D.L., Nasta, S., Tsai, D., Loren, A.W., Siegel, D.L., Glatstein, E., Alavi, A., Stadtmauer, E.A. Schuster, S.J. (2006) Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplantation, 38, 211 216.
33. Sweetenham, J.W., Taghipour, G., Milligan, D., Blystad, A.K., Caballero, D., Fassas, A. Goldstone, A.H. (1997) High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 20, 745 752.
34. Sweetenham, J.W., Carella, A.M., Taghipour, G., Cunningham, D., Marcus, R., Della Volpe, A., Linch, D.C., Schmitz, N. Goldstone, A.H. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology, 17, 3101 3109.
35. Yahalom, J. (2005) Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). European Journal of Haematology, 75 (Suppl. 66 90 97.
36. Yuen, A.R., Rosenberg, S.A., Hoppe, R.T., Halpern, J.D. Horning, S.J. (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood, 89, 814 822.